Market Cap

Solid Biosciences Inc. Market Capitalization:

$424.6 Million

USD as of Jan. 1, 2026

business Solid Biosciences Inc. Company Profile

Solid Biosciences Inc. Main Stock Listing

NASDAQ: SLDB

Market Capitalization History of Solid Biosciences Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Solid Biosciences Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $424.6 M 231.07%
Jan. 1, 2025 $128.3 M 14.94%
Jan. 1, 2024 $111.6 M -20.08%
Jan. 1, 2023 $139.6 M 462.70%
Jan. 1, 2022 $24.8 M -81.29%
Jan. 1, 2021 $132.6 M 94.63%
Jan. 1, 2020 $68.1 M -86.69%
Jan. 1, 2019 $511.9 M -1.76%
Jan. 1, 2018 $521.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Solid Biosciences Inc. Categories

United States languages Healthcare languages Drug Manufacturers—Specialty & Generic
United States Healthcare United States Drug Manufacturers—Specialty & Generic

Stocks & Indices

Solid Biosciences Inc. has the following listings and related stock indices.


Stock: NASDAQ: SLDB

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.